BTK and pemphigus: Several novel therapeutic strategies targeting B cells have been in investigational or clinical trials for the treatment of pemphigus, and those included anti-CD20 antibodies and Bruton's tyrosine kinase inhibitors (BTKI) targeting B cell receptor signaling (25).